China · Delayed Price · Currency is CNY Acrobiosystems Statistics
Total Valuation
Acrobiosystems has a market cap or net worth of CNY 10.44 billion. The enterprise value is 8.63 billion.
| Market Cap | 10.44B |
| Enterprise Value | 8.63B |
Important Dates
The next estimated earnings date is Tuesday, April 21, 2026.
| Earnings Date | Apr 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Acrobiosystems has 166.73 million shares outstanding. The number of shares has increased by 0.12% in one year.
| Current Share Class | 166.73M |
| Shares Outstanding | 166.73M |
| Shares Change (YoY) | +0.12% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 37.09% |
| Owned by Institutions (%) | 13.24% |
| Float | 89.32M |
Valuation Ratios
The trailing PE ratio is 60.85 and the forward PE ratio is 36.62.
| PE Ratio | 60.85 |
| Forward PE | 36.62 |
| PS Ratio | 13.14 |
| PB Ratio | 3.96 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 657.21 |
| P/OCF Ratio | 60.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.36, with an EV/FCF ratio of 543.05.
| EV / Earnings | 49.93 |
| EV / Sales | 10.86 |
| EV / EBITDA | 44.36 |
| EV / EBIT | 62.46 |
| EV / FCF | 543.05 |
Financial Position
The company has a current ratio of 12.90, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.90 |
| Quick Ratio | 11.31 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 3.73 |
| Interest Coverage | 25.32 |
Financial Efficiency
Return on equity (ROE) is 6.64% and return on invested capital (ROIC) is 15.39%.
| Return on Equity (ROE) | 6.64% |
| Return on Assets (ROA) | 3.01% |
| Return on Invested Capital (ROIC) | 15.39% |
| Return on Capital Employed (ROCE) | 5.02% |
| Revenue Per Employee | 914,295 |
| Profits Per Employee | 198,813 |
| Employee Count | 869 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.52 |
Taxes
In the past 12 months, Acrobiosystems has paid 10.54 million in taxes.
| Income Tax | 10.54M |
| Effective Tax Rate | 5.75% |
Stock Price Statistics
The stock price has increased by +69.20% in the last 52 weeks. The beta is 0.99, so Acrobiosystems's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +69.20% |
| 50-Day Moving Average | 57.02 |
| 200-Day Moving Average | 50.69 |
| Relative Strength Index (RSI) | 71.82 |
| Average Volume (20 Days) | 1,810,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Acrobiosystems had revenue of CNY 794.52 million and earned 172.77 million in profits. Earnings per share was 1.03.
| Revenue | 794.52M |
| Gross Profit | 682.74M |
| Operating Income | 138.12M |
| Pretax Income | 183.25M |
| Net Income | 172.77M |
| EBITDA | 172.33M |
| EBIT | 138.12M |
| Earnings Per Share (EPS) | 1.03 |
Balance Sheet
The company has 1.87 billion in cash and 59.25 million in debt, with a net cash position of 1.81 billion or 10.84 per share.
| Cash & Cash Equivalents | 1.87B |
| Total Debt | 59.25M |
| Net Cash | 1.81B |
| Net Cash Per Share | 10.84 |
| Equity (Book Value) | 2.64B |
| Book Value Per Share | 15.84 |
| Working Capital | 2.10B |
Cash Flow
In the last 12 months, operating cash flow was 173.00 million and capital expenditures -157.12 million, giving a free cash flow of 15.89 million.
| Operating Cash Flow | 173.00M |
| Capital Expenditures | -157.12M |
| Free Cash Flow | 15.89M |
| FCF Per Share | 0.10 |
Margins
Gross margin is 85.93%, with operating and profit margins of 17.38% and 21.75%.
| Gross Margin | 85.93% |
| Operating Margin | 17.38% |
| Pretax Margin | 23.06% |
| Profit Margin | 21.75% |
| EBITDA Margin | 21.69% |
| EBIT Margin | 17.38% |
| FCF Margin | 2.00% |
Dividends & Yields
This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 0.91%.
| Dividend Per Share | 0.57 |
| Dividend Yield | 0.91% |
| Dividend Growth (YoY) | -4.44% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 51.41% |
| Buyback Yield | -0.12% |
| Shareholder Yield | 0.82% |
| Earnings Yield | 1.65% |
| FCF Yield | 0.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Acrobiosystems has an Altman Z-Score of 15.4 and a Piotroski F-Score of 7.
| Altman Z-Score | 15.4 |
| Piotroski F-Score | 7 |